BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34344758)

  • 1. Chemerin Tips the Scales in ccRCC to Evade Ferroptosis.
    Reznik E; Jiang H; Hakimi AA
    Cancer Discov; 2021 Aug; 11(8):1879-1880. PubMed ID: 34344758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance.
    Tan SK; Mahmud I; Fontanesi F; Puchowicz M; Neumann CKA; Griswold AJ; Patel R; Dispagna M; Ahmed HH; Gonzalgo ML; Brown JM; Garrett TJ; Welford SM
    Cancer Discov; 2021 Aug; 11(8):2072-2093. PubMed ID: 33757970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma.
    Miess H; Dankworth B; Gouw AM; Rosenfeldt M; Schmitz W; Jiang M; Saunders B; Howell M; Downward J; Felsher DW; Peck B; Schulze A
    Oncogene; 2018 Oct; 37(40):5435-5450. PubMed ID: 29872221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC.
    Xue W; Jian W; Meng Y; Wang T; Cai L; Yu Y; Yu Y; Xia Z; Zhang C
    Cell Death Dis; 2023 Aug; 14(8):539. PubMed ID: 37604811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma.
    Zheng B; Niu Z; Si S; Zhao G; Wang J; Yao Z; Cheng F; He W
    Aging (Albany NY); 2021 Aug; 13(15):19789-19804. PubMed ID: 34370716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of the X-inactivation escaping gene
    Zheng Q; Li P; Zhou X; Qiang Y; Fan J; Lin Y; Chen Y; Guo J; Wang F; Xue H; Xiong J; Li F
    Theranostics; 2021; 11(18):8674-8691. PubMed ID: 34522206
    [No Abstract]   [Full Text] [Related]  

  • 7. ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.
    Klasson TD; LaGory EL; Zhao H; Huynh SK; Papandreou I; Moon EJ; Giaccia AJ
    Cancer Metab; 2022 Oct; 10(1):14. PubMed ID: 36192773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
    Wu G; Wang Q; Xu Y; Li Q; Cheng L
    Aging (Albany NY); 2020 Jul; 12(14):14933-14948. PubMed ID: 32688345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ultrasensitive GSH-specific fluorescent probe unveils celastrol-induced ccRCC ferroptosis.
    Li H; Deng C; Zhu N; Zhang C; Zeng Q; Qin L
    Bioorg Chem; 2023 May; 134():106454. PubMed ID: 36889199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting lipid biosynthesis on the basis of conventional treatments for clear cell renal cell carcinoma: A promising therapeutic approach.
    Guo T; Zhang X; Chen S; Wang X; Wang X
    Life Sci; 2024 Jan; 336():122329. PubMed ID: 38052321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma.
    Lu Y; Qin H; Jiang B; Lu W; Hao J; Cao W; Du L; Chen W; Zhao X; Guo H
    Cancer Lett; 2021 Dec; 522():1-13. PubMed ID: 34520818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
    Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
    BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between visceral adipose tissue and genetic mutations (VHL and KDM5C) in clear cell renal cell carcinoma.
    Greco F; Mallio CA
    Radiol Med; 2021 May; 126(5):645-651. PubMed ID: 33400184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis resistance determines high susceptibility of murine A/J strain to iron-induced renal carcinogenesis.
    Cheng Z; Akatsuka S; Li GH; Mori K; Takahashi T; Toyokuni S
    Cancer Sci; 2022 Jan; 113(1):65-78. PubMed ID: 34699654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.
    Chang K; Yuan C; Liu X
    Front Oncol; 2021; 11():649347. PubMed ID: 33996565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma.
    Shen K; Vesey DA; Ellis RJ; Del Vecchio SJ; Cho Y; Teixeira-Pinto A; McGuckin MA; Johnson DW; Gobe GC
    PLoS One; 2019; 14(1):e0210246. PubMed ID: 30653515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
    Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
    Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A robust ferroptosis-related gene signature predicts overall survival in clear cell renal cell carcinoma.
    Canxuan L; Dan L
    Future Oncol; 2021 Nov; 17(32):4321-4341. PubMed ID: 34369813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of sex-specific abdominal visceral fat as measured via CT as a predictor of clear renal cell carcinoma T stage.
    Guo H; Zhao W; Wang A; Li M; Ma H; Wang F; Wang Q; Ba X
    Adipocyte; 2021 Dec; 10(1):285-292. PubMed ID: 34014795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathway signature and cellular differentiation in clear cell renal cell carcinoma.
    Tun HW; Marlow LA; von Roemeling CA; Cooper SJ; Kreinest P; Wu K; Luxon BA; Sinha M; Anastasiadis PZ; Copland JA
    PLoS One; 2010 May; 5(5):e10696. PubMed ID: 20502531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.